Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
Rosiglitazone, a peroxisome proliferator-activated receptor γ agonist, has been used to treat type 2 diabetes. Despite debates regarding its cardioprotection, the effects of rosiglitazone on cardiac electrophysiology are still unclear. This study determined the effect of rosiglitazone on ventricular...
Saved in:
Main Authors: | Siripong Palee, Punate Weerateerangkul, Sirirat Surinkeaw, Siriporn Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79960699765&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49695 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
by: Palee S., et al.
Published: (2014) -
Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
by: Palee S., et al.
Published: (2014) -
Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion
by: Siripong Palee, et al.
Published: (2018) -
Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion
by: Siripong Palee, et al.
Published: (2018) -
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
by: Chayodom Maneechote, et al.
Published: (2018)